Trials / Completed
CompletedNCT00837733
Endometrial Local Injury and Implantation Failure
Endometrial Local Injury Improves the Pregnancy Rate Among Recurrent Implantation Failure Patients Undergoing IVF/ICSI
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- Yazd Research & Clinical Center for Infertility · Academic / Other
- Sex
- Female
- Age
- 15 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the influence of endometrial biopsy on increasing implantation rate in patients with recurrent implantation failures, 93 women with at least two implantation failures were evaluated. In case group endometrial biopsy was obtained from 48 patients in the luteal phase of previous cycle and implantation and clinical pregnancy rate were compared with 45 patients in control group. The results suggest that in vitro fertilization or intracytoplasmic sperm injection after endometrial biopsy increase pregnancy outcome.
Detailed description
In a randomized control trial study, 93 women with at least two implantation failures were evaluated. In case group endometrial biopsy was obtained from 48 patients in the luteal phase of previous cycle and implantation and clinical pregnancy rate were compared with 45 patients in control group. The implantation rate was determined as 10.9% in biopsy group compared with 3.38% in controls. Clinical pregnancy rate was significantly higher in case group than controls (27.1% and 8.9% respectively
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endometrial biopsy | Endometrial biopsy was done at luteal phase on the day 21-26 of spontaneous menstrual cycles, when GnRH agonist uses begun. Endometrial samples were taken by a biopsy catheter |
| PROCEDURE | Endometrial Biopsy | Biopsy catheter |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-11-01
- Completion
- 2008-12-01
- First posted
- 2009-02-05
- Last updated
- 2009-02-05
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00837733. Inclusion in this directory is not an endorsement.